Explore the pivotal role of the Moonshot Cancer Initiative and MCED Consortium in shaping the landscape of early cancer detection and screening, with a focus on innovative screening tools and legislative support.
Data Continue to Illustrate Potential Role of Partial Breast Irradiation in Early-Stage Breast Cancer
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
Richardson Discusses Implications of the FDA Withdrawal of Melflufen in Multiple Myeloma
FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL
Dana-Farber Cancer Institute Earns Fifth Consecutive Magnet® Designation Recognizing Excellence in Nursing Practice and Patient Care
Insider Insights: Unveiling Takeaways from AACR 2024
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma